Por favor, use este identificador para citar o enlazar este ítem: https://hdl.handle.net/10495/38529
Título : Comparison of four pharmacological strategies aimed to prevent the lung infammation and paraquat-induced alveolar damage
Autor : Buendía Rodríguez, Jefferson Antonio
Justinico Castro, José Armando
Tapia Vela, Laura Joanna
Sinisterra Espejo, Denis María
Sánchez Villamil, Juana Patricia
Zuluaga Salazar, Andrés Felipe
metadata.dc.subject.*: Antioxidantes - Farmacología
Antioxidants - pharmacology
Ácido Ascórbico - Farmacología
Ascorbic Acid - pharmacology
Atorvastatina
Atorvastatin
Pulmón
Lung
Paraquat
Ciclofosfamida
Cyclophosphamide
Dexametasona
Dexamethasone
Quimioterapia Combinada
Drug Therapy, Combination
Heparina de Bajo-Peso-Molecular
Heparin, Low-Molecular-Weight
Neumonía
Pneumonia
Alveolos Pulmonares
Pulmonary Alveoli
Fibrosis Pulmonar
Pulmonary Fibrosis
Ratas Wistar
Rats, Wistar
Resultado del Tratamiento
Treatment Outcome
https://id.nlm.nih.gov/mesh/D000975
https://id.nlm.nih.gov/mesh/D001205
https://id.nlm.nih.gov/mesh/D000069059
https://id.nlm.nih.gov/mesh/D008168
https://id.nlm.nih.gov/mesh/D010269
https://id.nlm.nih.gov/mesh/D003520
https://id.nlm.nih.gov/mesh/D003907
https://id.nlm.nih.gov/mesh/D004359
https://id.nlm.nih.gov/mesh/D006495
https://id.nlm.nih.gov/mesh/D011014
https://id.nlm.nih.gov/mesh/D011650
https://id.nlm.nih.gov/mesh/D011658
https://id.nlm.nih.gov/mesh/D017208
https://id.nlm.nih.gov/mesh/D016896
Fecha de publicación : 2019
Editorial : BMC (BioMed Central)
Citación : Buendía JA, Justinico Castro JA, Vela LJT, Sinisterra D, Sánchez Villamil JP, Zuluaga Salazar AF. Comparison of four pharmacological strategies aimed to prevent the lung inflammation and paraquat-induced alveolar damage. BMC Res Notes. 2019 Sep 18;12(1):584. doi: 10.1186/s13104-019-4598-0.
Resumen : ABSTRACT: Objective: The aim of this study was to compare in vivo efect of fve pharmacological options on infammation and pulmonary fbrosis induced by paraquat. Methods: 54 Wistar SPF rats were used. After 2 h post-intoxication with paraquat ion, groups of 9 animals were ran domly assigned to (1) cyclophosphamide plus dexamethasone (2) low molecular weight heparin (3) unfractionated heparin (4) vitamin C every 24 h, (5) atorvastatin or (6) placebo with intraperitoneal saline. Lung infammation, alveolar injury, hepatocyte damage, hepatic regeneration, acute tubular necrosis and kidney congestion were evaluated. Results: In the control group 100% of animals presented moderate and severe lung infammation, while in the groups with atorvastatin and intratracheal heparin this proportion was lower (55.5%; CI 26.6–81.3%) (p=0.025). A lower degree of moderate or severe hepatic regeneration was evident in the treatment groups with atorvastatin (p=0.009). In this study was demonstrated that statins and heparin might have a protective efect in the paraquat induced destructive phase. More evidence is needed to evaluated of dose–response efects of these drugs before to study in clinical trials
metadata.dc.identifier.eissn: 1756-0500
metadata.dc.identifier.doi: 10.1186/s13104-019-4598-0
Aparece en las colecciones: Artículos de Revista en Ciencias Médicas

Ficheros en este ítem:
Fichero Descripción Tamaño Formato  
BuendiaJefferson_2019_Comparison_Four_Pharmacological_Strategies.pdfArtículo de investigación810.18 kBAdobe PDFVisualizar/Abrir


Este ítem está sujeto a una licencia Creative Commons Licencia Creative Commons Creative Commons